nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Bayesian Network Meta-analysis of Systemic Treatments for Metastatic Castration-Resistant Prostate Cancer in First- and Subsequent Lines
|
Wosny, Marie |
|
|
20 |
4 |
p. 569-595 |
artikel |
2 |
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
|
Siu, Lillian L. |
|
|
20 |
4 |
p. 637-649 |
artikel |
3 |
A Podcast on Integrating Genetic Testing for Homologous Recombination Repair Gene Alterations in Patients with Prostate Cancer in the USA: a Multidisciplinary Approach to Overcoming the Obstacles
|
Szymaniak, Brittany M. |
|
|
20 |
4 |
p. 543-550 |
artikel |
4 |
Circulating Tumor DNA in Advanced EGFRex20+ NSCLC: Concordance with Tissue Biopsy, Monitoring of Response, and Resistance to High-Dose Osimertinib
|
Zwierenga, Fenneke |
|
|
20 |
4 |
p. 663-677 |
artikel |
5 |
Comparative Effectiveness of Atezolizumab Plus Bevacizumab Versus Tremelimumab Plus Durvalumab in Patients with Hepatocellular Carcinoma (HCC) in a Real-World Setting
|
Lo Prinzi, Federica |
|
|
20 |
4 |
p. 707-713 |
artikel |
6 |
Discontinuation of Immune Checkpoint Inhibition in Patients with Advanced Unresectable Melanoma Achieving CR, PR, or SD
|
Czarnecka, Anna M. |
|
|
20 |
4 |
p. 693-705 |
artikel |
7 |
Efficacy and Safety of Anti-GD2 Immunotherapy with Dinutuximab Beta in the Treatment of Relapsed/Refractory High-Risk Neuroblastoma
|
Wieczorek, Aleksandra |
|
|
20 |
4 |
p. 551-568 |
artikel |
8 |
Precision Oncology in Rare Endocrine and Neuroendocrine Neoplasms: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
|
Dorman, Klara |
|
|
20 |
4 |
p. 715-724 |
artikel |
9 |
PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand Therapy
|
Kuo, Phillip H. |
|
|
20 |
4 |
p. 597-613 |
artikel |
10 |
Relationship of Prior Anticancer Treatments with Palbociclib Clinical Outcomes in Patients with HR+/HER2− Advanced Breast Cancer in Real-World Settings
|
Rocque, Gabrielle B. |
|
|
20 |
4 |
p. 679-692 |
artikel |
11 |
Relugolix in Combination with Androgen Receptor Pathway Inhibitors in the Treatment of Metastatic Prostate Cancer: A Clinical Perspective
|
Buchler, Tomas |
|
|
20 |
4 |
p. 627-635 |
artikel |
12 |
Role of immunotherapy in early breast cancer: past, present, and future
|
Britten, Karissa |
|
|
20 |
4 |
p. 615-625 |
artikel |
13 |
Streamlining and Accelerating the Molecular Tumor Board Process at the University Medical Center Hamburg-Eppendorf
|
Riemann, Layla Tabea |
|
|
20 |
4 |
p. 725-735 |
artikel |
14 |
Teclistamab Dosing in Responders: Modeling and Simulation Results from the MajesTEC-1 Study in Relapsed/Refractory Multiple Myeloma
|
Guo, Yue |
|
|
20 |
4 |
p. 651-661 |
artikel |